Human pathology

Home page > D. Systemic pathology > Metabolic diseases > Lafora disease

Lafora disease

Lafora?s disease

Lafora disease is an inborn error of carbohydrate metabolism with storage of a polyglucosan in various tissues including brain and liver. Lafora disease is characterized by pathognomonic inclusions, Lafora bodies (LB), in neurons and other cell types.

Microscopic synopsis

- brain
- skin

  • PAS-positive inclusions in numerous peripheral cells of eccrine sweat ducts, in eccrine sweat glands or in apocrine sweat glands (6796905, 14663053)

- skeletal muscle
- peripheral nerve
- liver: hepatic Lafora disease (2172143)

- heart

Differential diagnosis

- Lafora-like bodies (Lafora body like inclusions)

  • isolated (2172143)
  • alcohol aversion therapy by cyanamide or disulfiram

- type IV glycogenosis (amylopectinosis)

Electron microscopy

- the inclusions consisted of polyglucosan-type material, not bounded by a membrane (6791573)

Etiology

- germline mutations in the EPM2A gene coding for laforin protein at 6q24
- germline mutations in the NHLRC1 gene coding for malin at 6p22.3

References

- Ganesh S, Puri R, Singh S, Mittal S, Dubey D. Recent advances in the molecular basis of Lafora?s progressive myoclonus epilepsy. J Hum Genet. 2005 Nov 26; PMID: 16311711

- Andrade DM, Ackerley CA, Minett TS, Teive HA, Bohlega S, Scherer SW, Minassian BA. Skin biopsy in Lafora disease: genotype-phenotype correlations and diagnostic pitfalls. Neurology. 2003 Dec 9;61(11):1611-4. PMID: 14663053

- Ng IO, Sturgess RP, Williams R, Portmann B. Ground-glass hepatocytes with Lafora body like inclusions?histochemical, immunohistochemical and electronmicroscopic characterization. Histopathology. 1990 Aug;17(2):109-15. PMID: 2172143